Press Resease

Drug Discovery Services Market by Type (Pharmacokinetics and Drug Metabolism, Biology Services, and Medicinal Chemistry), by Process (Target Validation, Target Selection, Hit-To-Lead Identification, Candidate Validation, and Lead Optimization), by Drug Type (Biologics and Small Molecules), and by Therapeutic Area (Neurology, Diabetes, Oncology, Respiratory Diseases, Cardiovascular Diseases, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 26-Feb-2019 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-2876 Status : Published

Global drug discovery services market expected to generate around USD 20.29 billion by 2025, at a CAGR of around 11.9% between 2019 and 2025. The rising expenditure on research and development, growing inclination of pharmaceutical companies toward outsourcing to evade hurdles driving the market growth globally.

Description

The report covers a forecast and an analysis of the drug discovery services market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the drug discovery services market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the drug discovery services market on a global and regional level.

In order to give the users of this report a comprehensive view of the drug discovery services market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Drug Discovery Services Market

The report provides company market share analysis to give a broader overview of the key players in the drug discovery services market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the drug discovery services market on a global and regional basis.

The study provides a decisive view of the drug discovery services market by segmenting the market based on type, process, drug type, therapeutic area, and region. By type, the drug discovery services market is segmented into pharmacokinetics and drug metabolism, biology services, and medicinal chemistry. The process segment includes target validation, target selection, hit-to-lead identification, candidate validation, and lead optimization. The drug type segment includes biologics and small molecules. The therapeutic area segment includes neurology, diabetes, oncology, respiratory diseases, cardiovascular diseases, and others.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some key players of the global drug discovery services market are Albany Molecular Research Inc. (AMRI), Thermo Fisher Scientific, Evotec, Charles River Laboratories International, Domainex, Covance, GenScript, Selcia Limited, WuXiAppTec, Viva Biotech, Pharmaceutical Product Development, LLC, and SRI International, among others.

This report segments the global drug discovery services market into:

Global Drug Discovery Services Market: By Type

  • Pharmacokinetics and Drug Metabolism
  • Biology Services
  • Medicinal Chemistry

Global Drug Discovery Services Market: By Process

  • Target Validation
  • Target Selection
  • Hit-To-Lead Identification
  • Candidate Validation
  • Lead Optimization

Global Drug Discovery Services Market: By Drug Type

  • Biologics
  • Small Molecules

Global Drug Discovery Services Market: By Therapeutic Area

  • Neurology
  • Diabetes
  • Oncology
  • Respiratory Diseases
  • Cardiovascular Diseases
  • Others

Global Drug Discovery Services Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Drug Discovery Services market, 2018-2025(USD Billion)
    • 2.2. Global Drug Discovery Services market: Snapshot
  •  
  • Chapter 3. Drug Discovery Services Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Rising expenditure on research and development
      • 3.2.2. Growing inclination of pharmaceutical companies toward outsourcing to evade hurdles
    • 3.3. Market Restraints
      • 3.3.1. High costs of drug discovery
      • 3.3.2. Strict guidelines in some regions
    • 3.4. Opportunities
      • 3.4.1. Patent expiry of current products
      • 3.4.2. Technological improvements in drug discovery services
    • 3.5. Porter's Five Forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Type
      • 3.6.2. Market attractiveness analysis, by Process
      • 3.6.3. Market attractiveness analysis, by Drug Type
      • 3.6.4. Market attractiveness analysis, by Therapeutic Area
  •  
  • Chapter 4. Global Drug Discovery Services Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Drug Discovery Services market: company market share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Drug Discovery Services Market - Type Analysis
    • 5.1. Global Drug Discovery Services market: Type overview
      • 5.1.1. Global Drug Discovery Services market revenue share, by Type, 2018 and 2025
    • 5.2. Pharmacokinetics and Drug Metabolism
      • 5.2.1. Global Drug Discovery Services market for Pharmacokinetics and Drug Metabolism, 2016-2025 (USD Billion)
    • 5.3. Biology Services
      • 5.3.1. Global Drug Discovery Services market for Biology Services, 2016-2025 (USD Billion)
    • 5.4. Medicinal Chemistry
      • 5.4.1. Global Drug Discovery Services market for Medicinal Chemistry, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global Drug Discovery Services Market - Process Analysis
    • 6.1. Global Drug Discovery Services market: Process overview
      • 6.1.1. Global Drug Discovery Services market revenue share, by Process, 2018 and 2025
    • 6.2. Target Validation
      • 6.2.1. Global Drug Discovery Services market for Target Validation, 2016-2025 (USD Billion)
    • 6.3. Target Selection
      • 6.3.1. Global Drug Discovery Services market for Target Selection, 2016-2025 (USD Billion)
    • 6.4. Hit-to-lead Identification
      • 6.4.1. Global Drug Discovery Services market for Hit-to-lead Identification, 2016-2025 (USD Billion)
    • 6.5. Candidate Validation
      • 6.5.1. Global Drug Discovery Services market for Candidate Validation, 2016-2025 (USD Billion)
    • 6.6. Lead Optimization
      • 6.6.1. Global Drug Discovery Services market for Lead Optimization, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global Drug Discovery Services Market - Drug Type Analysis
    • 7.1. Global Drug Discovery Services market: Drug Type overview
      • 7.1.1. Global Drug Discovery Services market revenue share, by Drug Type, 2018 and 2025
    • 7.2. Biologics
      • 7.2.1. Global Drug Discovery Services market for Biologics, 2016-2025 (USD Billion)
    • 7.3. Small Molecules
      • 7.3.1. Global Drug Discovery Services market for Small Molecules, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Global Drug Discovery Services Market - Therapeutic Area Analysis
    • 8.1. Global Drug Discovery Services market: Therapeutic Area overview
      • 8.1.1. Global Drug Discovery Services market revenue share, by Therapeutic Area, 2018 and 2025
    • 8.2. Neurology
      • 8.2.1. Global Drug Discovery Services market for Neurology, 2016-2025 (USD Billion)
    • 8.3. Diabetes
      • 8.3.1. Global Drug Discovery Services market for Diabetes, 2016-2025 (USD Billion)
    • 8.4. Oncology
      • 8.4.1. Global Drug Discovery Services market for Oncology, 2016-2025 (USD Billion)
    • 8.5. Respiratory Diseases
      • 8.5.1. Global Drug Discovery Services market for Respiratory Diseases, 2016-2025 (USD Billion)
    • 8.6. Cardiovascular Diseases
      • 8.6.1. Global Drug Discovery Services market for Cardiovascular Diseases, 2016-2025 (USD Billion)
    • 8.7. Others
      • 8.7.1. Global Drug Discovery Services market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 9. Global Drug Discovery Services Market - Regional Analysis
    • 9.1. Global Drug Discovery Services market: Regional overview
      • 9.1.1. Global Drug Discovery Services market revenue share, by region, 2018 and 2025
    • 9.2. North America
      • 9.2.1. North America Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.2.2. North America Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.2.3. North America Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.2.4. North America Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
      • 9.2.5. The U.S.
        • 9.2.5.1. The U.S. Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
        • 9.2.5.2. The U.S. Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
        • 9.2.5.3. The U.S. Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
        • 9.2.5.4. The U.S. Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
      • 9.2.6. Rest of North America
        • 9.2.6.1. Rest of North America Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
        • 9.2.6.2. Rest of North America Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
        • 9.2.6.3. Rest of North America Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
        • 9.2.6.4. Rest of North America Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.3. Europe
      • 9.3.1. Europe Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.3.2. Europe Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.3.3. Europe Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.3.4. Europe Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
      • 9.3.5. Germany
        • 9.3.5.1. Germany Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
        • 9.3.5.2. Germany Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
        • 9.3.5.3. Germany Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
        • 9.3.5.4. Germany Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
      • 9.3.6. UK
        • 9.3.6.1. UK Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
        • 9.3.6.2. UK Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
        • 9.3.6.3. UK Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
        • 9.3.6.4. UK Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
      • 9.3.7. France
        • 9.3.7.1. France Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
        • 9.3.7.2. France Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
        • 9.3.7.3. France Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
        • 9.3.7.4. France Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
      • 9.3.8. Rest of Europe
        • 9.3.8.1. Rest of Europe Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
        • 9.3.8.2. Rest of Europe Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
        • 9.3.8.3. Rest of Europe Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
        • 9.3.8.4. Rest of Europe Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.4.2. Asia Pacific Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.4.3. Asia Pacific Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.4.4. Asia Pacific Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
      • 9.4.5. China
        • 9.4.5.1. China Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
        • 9.4.5.2. China Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
        • 9.4.5.3. China Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
        • 9.4.5.4. China Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
      • 9.4.6. Japan
        • 9.4.6.1. Japan Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
        • 9.4.6.2. Japan Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
        • 9.4.6.3. Japan Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
        • 9.4.6.4. Japan Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
      • 9.4.7. India
        • 9.4.7.1. India Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
        • 9.4.7.2. India Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
        • 9.4.7.3. India Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
        • 9.4.7.4. India Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
      • 9.4.8. Rest of Asia Pacific
        • 9.4.8.1. Rest of Asia Pacific Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
        • 9.4.8.2. Rest of Asia Pacific Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
        • 9.4.8.3. Rest of Asia Pacific Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
        • 9.4.8.4. Rest of Asia Pacific Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.5. Latin America
      • 9.5.1. Latin America Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.5.2. Latin America Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.5.3. Latin America Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.5.4. Latin America Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
      • 9.5.5. Brazil
        • 9.5.5.1. Brazil Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
        • 9.5.5.2. Brazil Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
        • 9.5.5.3. Brazil Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
        • 9.5.5.4. Brazil Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
      • 9.5.6. Rest of Latin America
        • 9.5.6.1. Rest of Latin America Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
        • 9.5.6.2. Rest of Latin America Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
        • 9.5.6.3. Rest of Latin America Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
        • 9.5.6.4. Rest of Latin America Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
    • 9.6. The Middle East and Africa
      • 9.6.1. The Middle East and Africa Drug Discovery Services market revenue, by Type, 2016-2025 (USD Billion)
      • 9.6.2. The Middle East and Africa Drug Discovery Services market revenue, by Process, 2016-2025 (USD Billion)
      • 9.6.3. The Middle East and Africa Drug Discovery Services market revenue, by Drug Type, 2016-2025 (USD Billion)
      • 9.6.4. The Middle East and Africa Drug Discovery Services market revenue, by Therapeutic Area, 2016-2025 (USD Billion)
  •  
  • Chapter 10. Company Profile
    • 10.1. Albany Molecular Research Inc. (AMRI)
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Drug Type portfolio
      • 10.1.4. Business strategy
      • 10.1.5. Recent developments
    • 10.2. Thermo Fisher Scientific
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Drug Type portfolio
      • 10.2.4. Business strategy
      • 10.2.5. Recent developments
    • 10.3. Biogen
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Drug Type portfolio
      • 10.3.4. Business strategy
      • 10.3.5. Recent developments
    • 10.4. Evotec
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Drug Type portfolio
      • 10.4.4. Business strategy
      • 10.4.5. Recent developments
      • 10.5. Charles River Laboratories International
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Drug Type portfolio
      • 10.5.4. Business strategy
      • 10.5.5. Recent developments
    • 10.6. Domainex
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Drug Type portfolio
      • 10.6.4. Business strategy
      • 10.6.5. Recent developments
    • 10.7. Covance
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Drug Type portfolio
      • 10.7.4. Business strategy
      • 10.7.5. Recent developments
    • 10.8. GenScript
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Drug Type portfolio
      • 10.8.4. Business strategy
      • 10.8.5. Recent developments
    • 10.9. Selcia Limited
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Drug Type portfolio
      • 10.9.4. Business strategy
      • 10.9.5. Recent developments
    • 10.10. WuXiAppTec
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Drug Type portfolio
      • 10.10.4. Business strategy
      • 10.10.5. Recent developments
    • 10.11. Viva Biotech
      • 10.11.1. Overview
      • 10.11.2. Financials
      • 10.11.3. Drug Type portfolio
      • 10.11.4. Business strategy
      • 10.11.5. Recent developments
    • 10.12. Pharmaceutical Product Development, LLC
      • 10.12.1. Overview
      • 10.12.2. Financials
      • 10.12.3. Drug Type portfolio
      • 10.12.4. Business strategy
      • 10.12.5. Recent developments
    • 10.13. SRI International
      • 10.13.1. Overview
      • 10.13.2. Financials
      • 10.13.3. Drug Type portfolio
      • 10.13.4. Business strategy
      • 10.13.5. Recent developments

Methodology

Free Analysis

Drug discovery is the procedure by which new medications are developed. In the past, drugs were discovered by detecting the active component from traditional preparations. Contemporary drug discovery encompasses the identification of screening successes, optimization, and medicinal chemistry of those successes to surge the selectivity, affinity, efficacy/potency, oral bioavailability, and metabolic stability. Post the compound identification that satisfies all of these necessities, the drug development process preceding clinical trials is initiated. Due to prolonged procedures, the contemporary drug discovery procedure is more often expensive that requires huge investments by pharmaceutical companies. Drug discovery services help in reducing timelines and costs, which, in turn, play a major role in meeting the drug discovery landmarks. Drug discovery services include drug target recognition, drug discovery selection, and drug design based on the fragment, lead compound recognition, and lead optimization.

The rising expenditure on research and development, growing inclination of pharmaceutical companies toward outsourcing to evade hurdles, increasing incidences of cancer and other life-threatening diseases, growing awareness regarding the use of new drugs, and increasing geriatric population worldwide are likely to be major driving the growth of the global drug discovery services market in the future. Patent expiry of current products and technological improvements in drug discovery services due to an increased focus on research and development is anticipated to create new market opportunities in the drug discovery services market over the estimated timeframe. Nonetheless, high costs associated with drug discovery, strict guidelines in some regions, and the drug testing on animals may restrict the global drug discovery services market.

Global Drug Discovery Services Market

The global drug discovery services market has been split into type, process, drug type, and therapeutic area. By type, the drug discovery services market is segmented into pharmacokinetics and drug metabolism, biology services, and medicinal chemistry. The process segment includes target validation, target selection, hit-to-lead identification, candidate validation, and lead optimization. The drug type segment includes biologics and small molecules. The therapeutic area segment includes neurology, diabetes, oncology, respiratory diseases, cardiovascular diseases, and others. The oncology segment is expected to hold a major market share in the future, owing to the increasing cases of cancer, growing tobacco usage, and unhealthy diets of people.

By region, North America is likely to lead the global drug discovery services market over the forecast time period. This can be attributed to the growing prevalence of chronic and auto-immune disorders, the presence of leading market players, availability of advanced healthcare infrastructure, and quick implementation of the latest technologies. Europe is anticipated be the second largest regional market in the years ahead, due to the increasing number of cancer and diabetes cases, growing geriatric population base, advantageous reimbursement scenario, and the presence of state-of-the-art healthcare infrastructure. The Asia Pacific market is projected to grow considerably over the estimated timeframe, due to the growing cases of cancer owing to high tobacco usage, and increasing demand for small molecules and biologics.

Some key players of the global drug discovery services market are Albany Molecular Research Inc. (AMRI), Thermo Fisher Scientific, Evotec, Charles River Laboratories International, Domainex, Covance, GenScript, Selcia Limited, WuXiAppTec, Viva Biotech, Pharmaceutical Product Development, LLC, and SRI International, among others.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com